Therapeutic Plasma Exchange Management for a Pediatric Patient Presenting With Immune Thrombotic Thrombocytopenic Purpura in a Setting of Common Variable Immunodeficiency

被引:0
|
作者
Budhipramono, Albert [1 ]
Sharma, Ruchika [2 ,3 ]
Wysocki, Christian Allen [2 ,4 ]
Zia, Ayesha N. [2 ,3 ]
Adkins, Brian D. [1 ,2 ]
机构
[1] Univ Texas Southwestern Med Ctr, Dept Pathol, Dallas, TX 75390 USA
[2] Childrens Hlth Syst, Dallas, TX 75235 USA
[3] Univ Texas Southwestern Med Ctr, Dept Pediat, Div Hematol & Oncol, Dallas, TX USA
[4] Univ Texas Southwestern Med Ctr, Dept Pediat, Div Allergy & Immunol, Dallas, TX USA
关键词
common variable immunodeficiency; pediatric apheresis; thrombotic thrombocytopenic purpura; CAPLACIZUMAB; SCORE; MICROANGIOPATHY; DEFICIENCY; RITUXIMAB; ANTIBODY; REGISTRY; TTP;
D O I
10.1002/jca.22154
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Common variable immunodeficiency (CVID) is a disorder characterized by hypogammaglobulinemia resulting in recurrent infections. While autoimmune disorders are common in patients with CVID, no association has been reported between CVID and immune thrombotic thrombocytopenic purpura (iTTP), a disorder most often caused by autoantibodies that compromise the activity of the enzyme ADAMTS13. Reduced ADAMTS13 activity results in the accumulation of large von Willebrand factor multimers that can consume platelets and cause microvascular thrombosis and organ injury, ultimately resulting in mortality in most cases of untreated iTTP. Here, we report a 12-year-old male with CVID who developed iTTP, underwent therapeutic plasma exchange (TPE), and subsequently recovered. We conducted a systematic review for other cases of CVID co-occurring with iTTP and present additional cases of this rare presentation. We highlight the importance of prompt recognition of iTTP in a patient with CVID and timely initiation of TPE.
引用
收藏
页数:6
相关论文
共 50 条
  • [31] Long-term remission in a patient with refractory thrombotic thrombocytopenic purpura treated with rituximab and plasma exchange
    A. L. Basquiera
    J. C. Damonte
    P. Abichaín
    A. G. Sturich
    J. J. García
    Annals of Hematology, 2008, 87 : 321 - 323
  • [32] Strong association between insufficient plasma exchange and fatal outcomes in Japanese patients with immune-mediated thrombotic thrombocytopenic purpura
    Kayashima, Michinori
    Sakai, Kazuya
    Harada, Kazuki
    Kanetake, Jun
    Kubo, Masayuki
    Hamada, Eriko
    Hayakawa, Masaki
    Hatakeyama, Kinta
    Matsumoto, Masanori
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2021, 114 (04) : 415 - 423
  • [33] Venous thrombo-embolism during immune-mediated thrombotic thrombocytopenic purpura is prevalent in patients with a prolonged treatment with therapeutic plasma exchange
    Benhamou, Y.
    Sauvetre, G.
    Grange, S.
    Veyradier, A.
    Coppo, P.
    REVUE DE MEDECINE INTERNE, 2020, 41 (12): : 809 - 813
  • [34] A phase-II sequential case-series study of all patients presenting to four plasma exchange centres with presumed relapsed/refractory thrombotic thrombocytopenic purpura treated with rituximab
    Clark, William F.
    Rock, Gail
    Barth, David
    Arnold, Donald M.
    Webert, Kathyrn E.
    Yenson, Paul R.
    Kelton, John G.
    Li, Lihua
    Foley, Steven R.
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 170 (02) : 208 - 217
  • [35] Prevalence of Undiagnosed Common Variable Immunodeficiency in adult patients with Immune Thrombocytopenic Purpura. A single center experience
    Din, M. Ammad Ud
    Hussain, S. A.
    Mustafa, S. Shahzad
    EUROPEAN ANNALS OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 54 (03) : 140 - 143
  • [36] Safety and Efficacy of Cryoprecipitate-Poor Plasma as a Replacement Fluid for Therapeutic Plasma Exchange in Thrombotic Thrombocytopenic Purpura: A Single Center Retrospective Evaluation
    Stefanello, Bianca
    De Paula, Erich Vinicius
    Orsi, Fernanda Andrade
    Comenalli Marques, Jose Francisco, Jr.
    Roveri, Eduardo Gasparotto
    Colella, Marina Pereira
    Ozelo, Margareth Castro
    Annichino-Bizzacchi, Joyce Maria
    Addas-Carvalho, Marcelo
    JOURNAL OF CLINICAL APHERESIS, 2014, 29 (06) : 311 - 315
  • [37] Plasma Exchange and N-Acetylcysteine Therapy in a Case of Congenital Thrombotic Thrombocytopenic Purpura Presenting With Acute Renal Failure
    Coskun, Cagri
    Aksu, Tekin
    Gulhan, Bora
    Duzova, Ali
    Unal, Sule
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2025, 47 (01) : e65 - e67
  • [38] Therapeutic plasma exchange in patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: the 10-year experience of a single center
    Kim, Ji-Won
    Kim, Inho
    Oh, Kook-Hwan
    Yoon, Sung-Soo
    Oh, Myoung-Don
    Song, Yeong Wook
    Heo, Dae Seog
    Bang, Yung-Jue
    Han, Kyou-Sup
    Han, Jin Suk
    Park, Seonyang
    Kim, Byoung Kook
    HEMATOLOGY, 2011, 16 (02) : 73 - 79
  • [39] FULMINANT THROMBOTIC THROMBOCYTOPENIC PURPURA IN A PATIENT WITH THE LIMITED FORM OF SCLERODERMA - SUCCESSFUL OUTCOME USING PLASMA-EXCHANGE
    COOKSON, S
    KRUEGER, ML
    BENNETT, RM
    JOURNAL OF RHEUMATOLOGY, 1991, 18 (06) : 900 - 901
  • [40] Successful management of three patients with autoimmune thrombotic thrombocytopenic purpura with paradigm-changing therapy: Caplacizumab, steroids, plasma exchange, rituximab, and intravenous immunoglobulins (CASPERI)
    Cid, Joan
    Isabel Perez-Valencia, Amanda
    Angel Torrente, Miguel
    Avarez-Larran, Alberto
    Diaz-Ricart, Maribel
    Esteve, Jordi
    Lozano, Miquel
    TRANSFUSION AND APHERESIS SCIENCE, 2021, 60 (01)